These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35775551)

  • 1. Diagnostic utility of GenoType MTBDR
    Yadav RN; Bhalla M; Kumar G; Sah GC; Dewan RK; Singhal R
    Int J Mycobacteriol; 2022; 11(2):183-189. PubMed ID: 35775551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlating clinical breakpoint concentration of moxifloxacin with gyrA mutations using the GenoType MTBDRsl assay Version 2.0.
    Sidiq Z; Hanif M; Dwivedi KK; Chopra KK; Khanna A; Vashishat BK
    Indian J Tuberc; 2023 Jul; 70(3):361-365. PubMed ID: 37562913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
    Heyckendorf J; Andres S; Köser CU; Olaru ID; Schön T; Sturegård E; Beckert P; Schleusener V; Kohl TA; Hillemann D; Moradigaravand D; Parkhill J; Peacock SJ; Niemann S; Lange C; Merker M
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype MTBDRsl version 2 and phenotypic drug resistance detection of
    Radhakrishnan R; Prabuseenivasan S; Hannah S; Vaishanavee V; Senthildevi V; Kannadhasan T; Suchithra R; Rajendran P; Chinnaiyan P; Jayabal L; Frederick A; Shanmugam S
    Int J Mycobacteriol; 2023; 12(3):299-304. PubMed ID: 37721236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of Specific
    Singh PK; Singh U; Jain A
    Microb Drug Resist; 2021 May; 27(5):647-651. PubMed ID: 32991238
    [No Abstract]   [Full Text] [Related]  

  • 6. Prediction of drug resistance profile of multidrug-resistant Mycobacterium tuberculosis (MDR-MTB) isolates from newly diagnosed case by whole genome sequencing (WGS): a study from a high tuberculosis burden country.
    Sun W; Gui X; Wu Z; Zhang Y; Yan L
    BMC Infect Dis; 2022 May; 22(1):499. PubMed ID: 35624432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New generation fluoroquinolone sitafloxacin could potentially overcome the majority levofloxacin and moxifloxacin resistance in multidrug-resistant
    Sun Q; Cheng K; Liao X; Zhao W; Wang C; Wang C; Yan J; Dong L; Wang F; Jiang G; Huang H; Guo Z; Wang G
    J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 39028256
    [No Abstract]   [Full Text] [Related]  

  • 8. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
    Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
    Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis.
    Qiao M; Ren W; Guo H; Huo F; Shang Y; Wang Y; Gao M; Pang Y
    Int J Infect Dis; 2021 May; 106():295-299. PubMed ID: 33864922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Resistant Tuberculosis on the Balkan Peninsula: Determination of Drug Resistance Mechanisms with Xpert MTB/XDR and Whole-Genome Sequencing Analysis.
    Truden S; Sodja E; Žolnir-Dovč M
    Microbiol Spectr; 2023 Mar; 11(2):e0276122. PubMed ID: 36877052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates.
    Kardan-Yamchi J; Amini S; Hamzelou G; Rahimi Foroushani A; Ghodousi A; Cirillo DM; Feizabadi MM
    Arch Microbiol; 2021 Sep; 203(7):3989-3996. PubMed ID: 34032874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
    Nosova EY; Bukatina AA; Isaeva YD; Makarova MV; Galkina KY; Moroz AM
    J Med Microbiol; 2013 Jan; 62(Pt 1):108-113. PubMed ID: 23019190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the GenoType MTBDR
    Gardee Y; Dreyer AW; Koornhof HJ; Omar SV; da Silva P; Bhyat Z; Ismail NA
    J Clin Microbiol; 2017 Mar; 55(3):791-800. PubMed ID: 27974543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis complex whole-genome sequencing in New York State: Implementation of a reduced phenotypic drug susceptibility testing algorithm.
    Shea J; Halse TA; Modestil H; Kearns C; Fowler RC; Da Costa-Carter CA; Siemetzki-Kapoor U; Leisner M; Lapierre P; Kohlerschmidt D; Rowlinson MC; Escuyer V; Musser KA
    Tuberculosis (Edinb); 2023 Sep; 142():102380. PubMed ID: 37543009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of GenoType MTBDR
    Ejo M; Van Deun A; Nunn A; Meredith S; Ahmed S; Dalai D; Tumenbayar O; Tsogt B; Dat PT; Ha DTM; Hang PT; Kokebu D; Teferi M; Mebrahtu T; Ngubane N; Moodliar R; Duckworth L; Conradie F; Enduwamahoro E; Keysers J; De Rijk P; Mulders W; Diro E; Rigouts L; de Jong BC; Torrea G
    Int J Tuberc Lung Dis; 2021 Oct; 25(10):839-845. PubMed ID: 34615581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India.
    Singh K; Kumari R; Gupta S; Tripathi R; Srivastava A; Shakya V; Gupta A; Anupurba S
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):56. PubMed ID: 34446022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.
    Kambli P; Ajbani K; Sadani M; Nikam C; Shetty A; Udwadia Z; Rodwell TC; Catanzaro A; Rodrigues C
    Tuberculosis (Edinb); 2015 Mar; 95(2):137-41. PubMed ID: 25522842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates.
    Chandramohan Y; Padmanaban V; Bethunaickan R; Tripathy S; Swaminathan S; Ranganathan UD
    J Glob Antimicrob Resist; 2019 Dec; 19():348-353. PubMed ID: 31226332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.